BioCentury | Dec 31, 2020
Deals

Dec. 30 Quick Takes: COVAXX-Aurobindo and Moderna-Recipharm in COVID deals; plus United-Y-mAbs, Zai-Cullinan and Incyte-Cellenkos

...exclusive rights from the Covaxx unit of United Biomedical Inc....
...Therapeutics Corp. Y-mAbs Therapeutics Inc. Memorial Sloan Kettering Cancer Center United Biomedical Inc. Aurobindo...
BioCentury | Nov 25, 2020
Product Development

Nov. 25 Quick Takes: FDA approves Y-mAbs’ Danyelza; plus NIH’s ACTT-4; COVAXX, Urovant, SomaLogic, Eluminex and Liquidia

...multiple countries including Brazil, Ecuador and Peru in exchange for more than $2.8 billion. The United Biomedical Inc....
...Generic), Olumiant (Other) Veklury, remdesivir (GS-5734) Beova, vibegron (KRP-114V, MK-4618, RVT-901, SNV004) LIQ861 NIH Gilead Sciences Inc. Eli Lilly and Co. Incyte Corp. United Biomedical Inc. Urovant...
BioCentury | Nov 25, 2020
Product Development

Steady stream of Phase III COVID-19 vaccine data to flow into the new year

...from Vaxxinity, formerly the COVAXX unit of United Biomedical Inc....
BioCentury | Nov 7, 2020
Emerging Company Profile

Vaxxinity: supplanting mAbs with vaccines for chronic disease

...Neuroscience Inc. and the Covaxx unit of United Biomedical Inc....
...different purposes. United Neuroscience spun out of United Biomedical Inc....
...commercial success in animal health, via parent company United Biomedical...
BioCentury | Jan 18, 2019
Clinical News

United Neuroscience's vaccine leads to 96% response rate in Chinese Phase IIa for Alzheimer's

...of UB-311 in about 41 of the patients. The company has exclusive, worldwide rights from United Biomedical Inc....
...Treat Alzheimer’s disease Endpoint: Safety and immunogenicity Status: Phase IIa data Milestone: NA Sandi Wong UBITh Amyloid-beta (UB-311) United Biomedical Inc. United...
BioCentury | May 4, 2018
Emerging Company Profile

Needling out Alzheimer’s

...synaptic and neuronal loss and improve cognition in AD patients. The company spun out of United Biomedical Inc....
...NASDAQ:ACIU), Lausanne, Switzerland Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Pfizer Inc. (NYSE:PFE), New York, N.Y. United Biomedical Inc....
...Alzheimer’s disease.” Alzheimer’s & Dementia: Translational Research & Clinical Interventions (2017) Jennie Walters, Staff Writer UB-312 UBITh Amyloid-beta (UB-311) United Biomedical Inc. United...
BioCentury | Jun 2, 2017
Clinical News

United Neuroscience reports Phase I data for AD vaccine UB-311

...United Neuroscience spun out of United Biomedical Inc. (Hauppauge, N.Y.) and received exclusive, worldwide rights to UB-311. United Biomedical Inc....
...Alzheimer’s disease Endpoint: Safety and immunogenicity Status: Phase I data Milestone: Phase II data (mid-2018) Alicia Parker UB-311 United Biomedical Inc. United...
BioCentury | Feb 10, 2011
Distillery Therapeutics

Indication: Infectious disease

...to prevent HIV infection. NanoViricides Inc.'s HivCide-I, a nanovirocide targeting gp120, is in preclinical testing. United Biomedical Inc....
BioCentury | Sep 20, 2010
Clinical News

Chiron, United Biomedical regulatory update

...which sells its test under a license from CHIR. CHIR and Ortho last week sued United Biomedical...
...prevent the manufacture, use, sale and export of HCV tests by United Biomedical, and unspecified damages. United Biomedical...
...immunoassays by Organon and its affiliates and United Biomedical in 10 European countries. Chiron Corp. (CHIR) United Biomedical Inc. WIR...
BioCentury | Oct 24, 2005
Company News

Liponex management update

...Hired: Kenneth Sokoll as VP of drug development, formerly VP of vaccine product development at United Biomedical Inc. WIR...
Items per page:
1 - 10 of 38
BioCentury | Dec 31, 2020
Deals

Dec. 30 Quick Takes: COVAXX-Aurobindo and Moderna-Recipharm in COVID deals; plus United-Y-mAbs, Zai-Cullinan and Incyte-Cellenkos

...exclusive rights from the Covaxx unit of United Biomedical Inc....
...Therapeutics Corp. Y-mAbs Therapeutics Inc. Memorial Sloan Kettering Cancer Center United Biomedical Inc. Aurobindo...
BioCentury | Nov 25, 2020
Product Development

Nov. 25 Quick Takes: FDA approves Y-mAbs’ Danyelza; plus NIH’s ACTT-4; COVAXX, Urovant, SomaLogic, Eluminex and Liquidia

...multiple countries including Brazil, Ecuador and Peru in exchange for more than $2.8 billion. The United Biomedical Inc....
...Generic), Olumiant (Other) Veklury, remdesivir (GS-5734) Beova, vibegron (KRP-114V, MK-4618, RVT-901, SNV004) LIQ861 NIH Gilead Sciences Inc. Eli Lilly and Co. Incyte Corp. United Biomedical Inc. Urovant...
BioCentury | Nov 25, 2020
Product Development

Steady stream of Phase III COVID-19 vaccine data to flow into the new year

...from Vaxxinity, formerly the COVAXX unit of United Biomedical Inc....
BioCentury | Nov 7, 2020
Emerging Company Profile

Vaxxinity: supplanting mAbs with vaccines for chronic disease

...Neuroscience Inc. and the Covaxx unit of United Biomedical Inc....
...different purposes. United Neuroscience spun out of United Biomedical Inc....
...commercial success in animal health, via parent company United Biomedical...
BioCentury | Jan 18, 2019
Clinical News

United Neuroscience's vaccine leads to 96% response rate in Chinese Phase IIa for Alzheimer's

...of UB-311 in about 41 of the patients. The company has exclusive, worldwide rights from United Biomedical Inc....
...Treat Alzheimer’s disease Endpoint: Safety and immunogenicity Status: Phase IIa data Milestone: NA Sandi Wong UBITh Amyloid-beta (UB-311) United Biomedical Inc. United...
BioCentury | May 4, 2018
Emerging Company Profile

Needling out Alzheimer’s

...synaptic and neuronal loss and improve cognition in AD patients. The company spun out of United Biomedical Inc....
...NASDAQ:ACIU), Lausanne, Switzerland Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Pfizer Inc. (NYSE:PFE), New York, N.Y. United Biomedical Inc....
...Alzheimer’s disease.” Alzheimer’s & Dementia: Translational Research & Clinical Interventions (2017) Jennie Walters, Staff Writer UB-312 UBITh Amyloid-beta (UB-311) United Biomedical Inc. United...
BioCentury | Jun 2, 2017
Clinical News

United Neuroscience reports Phase I data for AD vaccine UB-311

...United Neuroscience spun out of United Biomedical Inc. (Hauppauge, N.Y.) and received exclusive, worldwide rights to UB-311. United Biomedical Inc....
...Alzheimer’s disease Endpoint: Safety and immunogenicity Status: Phase I data Milestone: Phase II data (mid-2018) Alicia Parker UB-311 United Biomedical Inc. United...
BioCentury | Feb 10, 2011
Distillery Therapeutics

Indication: Infectious disease

...to prevent HIV infection. NanoViricides Inc.'s HivCide-I, a nanovirocide targeting gp120, is in preclinical testing. United Biomedical Inc....
BioCentury | Sep 20, 2010
Clinical News

Chiron, United Biomedical regulatory update

...which sells its test under a license from CHIR. CHIR and Ortho last week sued United Biomedical...
...prevent the manufacture, use, sale and export of HCV tests by United Biomedical, and unspecified damages. United Biomedical...
...immunoassays by Organon and its affiliates and United Biomedical in 10 European countries. Chiron Corp. (CHIR) United Biomedical Inc. WIR...
BioCentury | Oct 24, 2005
Company News

Liponex management update

...Hired: Kenneth Sokoll as VP of drug development, formerly VP of vaccine product development at United Biomedical Inc. WIR...
Items per page:
1 - 10 of 38